PhD
Scientist
Scientist
Dr. Timothy Cheung joined AmacaThera in 2024 as an expert in polymer chemistry, biomaterials and drug delivery. Since joining AmacaThera, he has been focused on expanding the uses of AmacaGel towards new APIs and combining its use with other medical devices. Timothy received his PhD in Chemistry from the University of Toronto and his BSc in Chemical Biology from McMaster University. His research focused on the synthesis of charged polymeric nanoparticles for the controlled release of growth factors from AmacaGel. He also developed novel polymeric excipients to increase RNA delivery efficiency from lipid nanoparticles. Prior to this, Timothy worked as an analytical chemist at Toronto Research Chemicals (now part of LGC Standards) and as a nanotoxicologist at National Research Council Canada.
Dr. Timothy Cheung joined AmacaThera in 2024 as an expert in polymer chemistry, biomaterials and drug delivery. Since joining AmacaThera, he has been focused on expanding the uses of AmacaGel towards new APIs and combining its use with other medical devices. Timothy received his PhD in Chemistry from the University of Toronto and his BSc in Chemical Biology from McMaster University. His research focused on the synthesis of charged polymeric nanoparticles for the controlled release of growth factors from AmacaGel. He also developed novel polymeric excipients to increase RNA delivery efficiency from lipid nanoparticles. Prior to this, Timothy worked as an analytical chemist at Toronto Research Chemicals (now part of LGC Standards) and as a nanotoxicologist at National Research Council Canada.